CAGT hero 2

Leaders in Developing and Applying Genomic Technologies

The Genomic Revolution promises the discovery of targeted approaches for treating disease. Innovations like CRISPR-based genome editing and comprehensive epigenomic profiling can inform, streamline and accelerate drug target discoveries, but piecing together this complex puzzle requires an interdisciplinary approach.

The Center for Advanced Genomic Technologies (CAGT) has assembled a team of world-leading engineers, scientists and physicians to integrate these technologies to unravel disease biology and discover new drug targets. By working together, we will catalyze a more robust biotechnology enterprise.

In the News

Purushothama Rao Tata

September 16, 2020 | Duke University

Lung Stem Cells in Transition - a Culprit in Lung Fibrosis

artistic rendering of DNA on black background

September 9, 2020

Diao awarded Genomic Innovator Awards

The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, selected Yarui Diao to receive 2020 Genomic Innovator Awards. NHGRI honored a total of 12 early career investigators in genomics.

Yarui Diao

September 1, 2020 | Duke School of Medicine

Diao awarded 2020 Genomic Innovator Award